Showing results (411-420 of 509) with videos related to

Sort By:
Pageof 51
Infectious Diseases Now|October 16, 2025
Evolution of the inappropriate use of broad-spectrum antibiotics for Pseudomonas aeruginosa infections following the 2022 CA-SFM guidelinesC Ourghanlian, D Kharchenko, V Fihman, et al.
Infectious Diseases Now|August 4, 2025
Artificial intelligence and infectious diseases: Scope and perspectivesS Abbara, Y Crabol, J Goupil de Bouillé, et al.
Infectious Diseases Now|March 27, 2025
Clinical significance of nosocomial Trichosporon asahii in urine: A retrospective cohort studyBruno Ali Lopez Luis, Karla Alhelí León-Palacios, Araceli Acosta-Ruiz, et al.
Infectious Diseases Now|October 25, 2020
Focus on patients receiving long-term antimicrobial treatments for lyme borreliosis: No lyme but mostly mental disordersO Itani, E Haddad, V Pitron, et al.
Infectious Diseases Now|January 15, 2023
Understanding and preventing vaccination errorsC Poiraud, L Réthoré, O Bourdon, et al.
Infectious Diseases Now|January 15, 2023
Outpatient parenteral antimicrobial therapy (OPAT) from an emergency model applied during the COVID-19 pandemic to standard of care: Preliminary lessons from our experienceG Giuliano, F Raffaelli, D Faliero, et al.
Infectious Diseases Now|July 1, 2021
Tocilizumab and COVID-19: Timing of administration assessmentQ Richier, V Jachiet, V Bonnemains, et al.
Infectious Diseases Now|July 1, 2021
Clustered cases of infections due to an uncommon methicillin-resistant Staphylococcus aureus originating in a maternity wardG Ménard, A Morin-Le Bihan, H Isly, et al.
Infectious Diseases Now|May 31, 2022
Probenecid, an old β-lactams pharmacokinetic enhancer for a renewed use: A retrospective studyP Huriez, C Ourghanlian, K Razazi, et al.
Infectious Diseases Now|June 6, 2022
The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO studyM Gueguen, L Khatchatourian, C Lohéac, et al.
Pageof 51